Growing community of inventors

Loughborough, United Kingdom

Timothy Johnson

Average Co-Inventor Count = 4.44

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 8

Timothy JohnsonMichael Stocks (3 patents)Timothy JohnsonNicholas David Kindon (2 patents)Timothy JohnsonAndrew Baxter (2 patents)Timothy JohnsonBryan Glyn Roberts (2 patents)Timothy JohnsonBarry John Teobald (1 patent)Timothy JohnsonLilian Alcaraz (1 patent)Timothy JohnsonNicholas Tomkinson (1 patent)Timothy JohnsonAndrew Bailey (1 patent)Timothy JohnsonRichard James Bull (1 patent)Timothy JohnsonJohn Steele (1 patent)Timothy JohnsonAndrew James Robbins (0 patent)Timothy JohnsonMichael John Stocks (1 patent)Timothy JohnsonAndrew Stuart Lister (1 patent)Timothy JohnsonAndrew James Robbins (1 patent)Timothy JohnsonMichael John Stocks (0 patent)Timothy JohnsonAndrew Stuart Lister (0 patent)Timothy JohnsonTimothy Johnson (3 patents)Michael StocksMichael Stocks (8 patents)Nicholas David KindonNicholas David Kindon (17 patents)Andrew BaxterAndrew Baxter (13 patents)Bryan Glyn RobertsBryan Glyn Roberts (8 patents)Barry John TeobaldBarry John Teobald (1 patent)Lilian AlcarazLilian Alcaraz (14 patents)Nicholas TomkinsonNicholas Tomkinson (5 patents)Andrew BaileyAndrew Bailey (3 patents)Richard James BullRichard James Bull (1 patent)John SteeleJohn Steele (2 patents)Andrew James RobbinsAndrew James Robbins (0 patent)Michael John StocksMichael John Stocks (3 patents)Andrew Stuart ListerAndrew Stuart Lister (1 patent)Andrew James RobbinsAndrew James Robbins (1 patent)Michael John StocksMichael John Stocks (0 patent)Andrew Stuart ListerAndrew Stuart Lister (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Astrazeneca Ab (3 from 1,500 patents)

2. Pulmagen Therapeutics Limited (0 patent)


3 patents:

1. 7662825 - N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases

2. 7410972 - Compounds

3. 7129246 - N-adamantlmethyl derivatives and intermediates as pharmaceutical compositions and processes for their preparation

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…